Cinclus Pharma
cincluspharma.com
Health Care
As featured in
Claim pageClaim
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
News
Cinclus Pharma Issues and Repurchases Class C Shares for Long-Term Incentive Program
Tipranks Press Release.
Read more
Report
Cinclus Pharma Holding AB: Cinclus Pharma has completed all patient visits in Phase III HEEALING1 study; topline results expected in Q4 2026
Cinclus Pharma Holding AB (publ), a clinical-stage pharmaceutical company developing next-generation treatments for acid-related diseases, announced today that the last patient has completed the final
Read more
Report
Interview with Christer Ahlberg in BioStock 2026-06-09 Read article about Cinclus Pharma with interview with CEO Christer Ahlberg from BioStock (in Swedish).
Read article about Cinclus Pharma with interview with CEO Christer Ahlberg from BioStock (in Swedish).
Read more
Report
Report
Claret Capital Partners invests €28M in Cinclus Pharma
Claret Capital Partners invests €28M in Cinclus Pharma Cinclus Pharma is a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases Claret Capital Partners providing growth funding of up to €28M to
Read more
Report
Lista: Aktierna på Stockholmsbörsen där analytikerna ser störst uppsida
Det finns sju aktier på Stockholmsbörsen där analytikerna ser en uppsida på minst 100%. Det visar Placeras genomgång av Factsets databas. Evolution…
Read more
Report
Report
Show more news
Financials
Total raised
$23.8M
Latest round
Venture - Series Unknown
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Venture - Series Unknown | 2020 | $23.8M | Details |